Novartis AG Mergers and Acquisitions


Novartis AG

Lichtstrasse 35
4056 Basel
Switzerland
Tel:41/61/324 11 11
URL: http://www.novartis.de
Primary Symbol & Exchange:
NOVN - Ordinary Shares - SWX Swiss Exchange
Other Symbol & Exchange:
NVS - ADR - New York Stock Exchange
Industry:
Pharmaceutical
Novartis AG Company Snapshot

Novartis AG Deal Timeline


Drag the timeline to see more deals; click on a deal to see details.


Acquisitions > 100 M$ 10 to 100 M$ < 10M$ Stakes Divestitures

Novartis AG M&A History


Novartis AG acquires Zhejiang Tianyuan Bio-pharm Co (pending) Novartis AG acquires  Zhejiang Tianyuan Bio-pharm Co (pending)Nov 04, 2009

CHINA - Novartis AG of Switzerland planned to acquire a ##% interest in Zhejiang Tianyuan Bio- Pharmaceutical Co, a Zhejiang- based manufacturer of vaccines, for CNY ### mil (USD ###.### mil).

Novartis AG acquires Ebewe Pharma GmbH-Specialty from Ebewe Pharma GmbH Novartis AG acquires  Ebewe Pharma GmbH-Specialty from Ebewe Pharma GmbHSep 24, 2009

AUSTRIA - Novartis AG of Switzerland acquired the specialty generic injectables business of Ebewe Pharma GmbH, an Unterach-based manufacturer and wholesaler of pharmaceutical products, for EUR ### mil (USD #.### bil) in cash.

Novartis Pharma AG acquires BTG Plc-HySolv Tech from BTG PLC Novartis Pharma AG acquires  BTG Plc-HySolv Tech from BTG PLCAug 28, 2009

UK - Novartis Pharma AG acquired Hysolv, a drug delivery technology owned by BTG Plc for USD ##.### mil/ assets. An initial payment of USD #.## mil was made, and an additional future payment of USD #.## mil

Novartis Option Fund intends to acquire a minority stake in Avila Therapeutics Inc Novartis Option Fund intends to acquire a minority stake in  Avila Therapeutics IncJul 27, 2009

US - Novartis Option Fund, a unit of Novartis AG's Novartis Venture Fund subsidiary, was granted an option to acquire an undisclosed minority stake in Avila Therapeutics Inc, a Waltham-based biotechnology company, for up to USD ### mil in

Novartis AG acquires a minority stake in Novartis India Ltd Novartis AG acquires a minority stake in  Novartis India LtdJun 25, 2009

INDIA ? Novartis AG of Switzerland completed its tender offer to raise its interest to ##.##% from ##. ##%, by acquiring a further ##.##% stake, or #.### mil ordinary shares in Novartis India Ltd, a pharmaceutical products manufacturer

Novartis AG acquires Mipharm SpA-Branches(2) from Mipharm SpA Novartis AG acquires  Mipharm SpA-Branches(2) from Mipharm SpAJun 09, 2009

ITALY - Novartis AG of Switzerland acquired two branches of Mipharm SpA, a Milan-based manufacturer of pharmaceuticals.

Novartis AG intends to acquire Elixir Pharmaceuticals Inc Novartis AG intends to acquire  Elixir Pharmaceuticals IncMay 19, 2009

US - Novartis AG of Switzerland was granted an option to acquire Elixir Pharmaceuticals Inc, a Cambridge-based pharmaceutical company, for an estimated USD ### mil, including up to an undisclosed amount in profit related payments.

Novartis AG is rumored to be planning to acquire Cubist Pharmaceuticals Inc Novartis AG is rumored to be planning to acquire  Cubist Pharmaceuticals IncApr 03, 2009

US - Novartis AG of Switzerland was rumored to be planning to acquire the entire share capital of Cubist Pharmaceuticals Inc, a Lexington-based biopharmaceutical company. Terms were not disclosed, but according to analyst estimates, the deal was valued at an

Novartis AG acquires Nektar Therapeutics-Pulmonary from Nektar Therapeutics Novartis AG acquires Nektar Therapeutics-Pulmonary from Nektar TherapeuticsDec 31, 2008

US - Novartis AG acquired the pulmonary business of Nektar Therapeutics, a manufacturer of biopharmaceuticals, for $### mil in cash. The transaction was to include certain dry powder and liquid pulmonary formulation and manufacturing assets, including capital equipment and manufacturing facility

Novartis AG acquires Protez Pharmaceuticals Inc Novartis AG acquires Protez Pharmaceuticals IncJul 17, 2008

US - Novartis AG acquired all the outstanding stock of Protez Pharmaceuticals Inc, a manufacturer of prescription pharmaceuticals, for an estimated $### mil. The consideration was consisted of $### mil and up to $### mil in profit related payments. The transaction

Novartis AG intends to purchase remaining interest in Speedel Holding AG Novartis AG intends to purchase remaining interest in  Speedel Holding AGJul 10, 2008

SWITZERLAND - Novartis AG (NV) planned to launch a mandatory tender offer to acquire the remaining ##.#% stake, or #.### mil ordinary shares, in Speedel Holding AG (SE), a Basel-based manufacturer of pharmaceutical products, for ### Swiss francs

Novartis AG acquires Speedel Holding AG Novartis AG acquires Speedel Holding AGJul 09, 2008

SWITZERLAND - Novartis AG (NV) raised its interest to ##.#% from #.#%, by acquiring a ##.#% interest, or #.## mil ordinary shares, in Speedel Holding AG (SE), a Basel-based manufacturer of pharmaceutical products, for ### Swiss

Novartis AG acquires a minority stake in Alcon Inc from Nestle SA Novartis AG acquires a minority stake in Alcon Inc from Nestle SAJul 08, 2008

US - Novartis AG (NA) acquired a ##% stake, or ##.### mil common shares, in Alcon Inc (AI), a manufacturer and wholesaler of pharmaceuticals, surgical equipment and devices, and contact lens care and other vision care products, from Nestle SA

Novartis AG intends to acquire Alcon Inc from Nestle SA Novartis AG intends to acquire  Alcon Inc from Nestle SAApr 07, 2008

US - Novartis AG (NA) was granted an option to raise its interest to ##% from ##% by acquiring a ##% interest, or ###.### mil common shares, in Alcon Inc (AI), a manufacturer and wholesaler of pharmaceuticals, surgical equipment and

Novartis AG acquires a minority stake in Intercell AG Novartis AG acquires a minority stake in Intercell AGSep 28, 2007

AUSTRIA - Novartis AG of Switzerland raised its stake to ##.#% from #.#%, by acquiring a #.#% stake, or #.# mil ordinary shares, in Intercell AG, a Vienna-based biotechnology company, for ##.## euros (##.###

Bayer Schering Pharma AG acquires Novartis AG-Biologics Mnfg from Novartis AG Bayer Schering Pharma AG acquires Novartis AG-Biologics Mnfg from Novartis AGSep 17, 2007

US - Bayer Schering Pharma AG, a majority-owned unit of Bayer AG, acquired the biologics manufacturing facility, located in Emeryville, California, of Novartis AG (NA), a manufacturer of pharmaceuticals, for $### mil. The transaction had been subject to regulatory approvals

Ciba Vision Corp acquires a minority stake in Ginko International Co Ltd Ciba Vision Corp acquires a minority stake in Ginko International Co LtdAug 22, 2007

CHINA - Ciba Vision Corp acquired an undisclosed minority stake in Ginko International Co Ltd, a contact lenses manufacturer, from Hydron International Ltd.

Novartis AG is rumored to be planning to acquire Bayer AG Novartis AG is rumored to be planning to acquire  Bayer AGAug 15, 2007

GERMANY - Novartis AG of Switzerland was rumored to be planning to acquire the entire ordinary share capital of Bayer AG, a Nordrhein-Westfalen-based manufacturer and wholesaler of pharmaceuticals.

Nestle SA acquires Novartis Medical Nutrition from Novartis AG Nestle SA acquires Novartis Medical Nutrition from Novartis AGJul 22, 2007

NETHERLAND - Nestle SA definitively acquired Novartis Medical Nutrition, a Nylon-based manufacturer of nutritional products, from Novartis AG, for #.### bil Swiss francs ($#.### bil US).

Jossa Arznei GmbH acquires HEXAL Pharma GmbH from Novartis AG Jossa Arznei GmbH acquires HEXAL Pharma GmbH from Novartis AGMay 21, 2007

GERMANY - Jossa Arznei GmbH acquired HEXAL Pharma GmbH, a Radebeul-based manufacturer of diagnostic pharmaceuticals, from Hexal AG, a unit of Novartis AG.

Novartis AG M&A Summary


Novartis AG has made 122 acquisitions while taking stakes in 43 companies. Novartis AG has 105 divestitures during this period.
YearAcquisitionsStakesDivestitures
2009311
2008220
2007133
2006104
2005513
2004411
2003413
2002413
2001519
2000613
1999628
1998348
1997308
1996528
19956612
1994708
1993755
1992812
1991764
1990813
1989636
1988801
1987301
1986300
1985210
1984101
1983200
1982000
1981200
Total12243105

Other Recent M&A in the Pharmaceutical industry